Total Payments
$795,055
2024 Payments
$140,419
Companies
53
Transactions
1,505
Medicare Patients
28,115
Medicare Billing
$5.7M
Payment Breakdown by Category
Other$383,738 (48.3%)
Royalty/License$182,953 (23.0%)
Consulting$170,465 (21.4%)
Food & Beverage$35,918 (4.5%)
Travel$20,689 (2.6%)
Research$1,230 (0.2%)
Education$62.85 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $328,738 | 205 | 41.3% |
| Royalty or License | $182,953 | 15 | 23.0% |
| Consulting Fee | $170,465 | 27 | 21.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $45,000 | 6 | 5.7% |
| Food and Beverage | $35,918 | 1,143 | 4.5% |
| Travel and Lodging | $20,689 | 102 | 2.6% |
| Grant | $10,000 | 1 | 1.3% |
| Unspecified | $1,230 | 2 | 0.2% |
| Education | $62.85 | 4 | 0.0% |
Payments by Type
General
$793,825
1,503 transactions
Research
$1,230
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurora Spine, Inc. | $337,609 | 35 | $0 (2024) |
| Medtronic USA, Inc. | $221,847 | 565 | $0 (2020) |
| Medtronic, Inc. | $221,047 | 420 | $0 (2024) |
| Abbott Laboratories | $4,424 | 132 | $0 (2024) |
| Boston Scientific Corporation | $2,707 | 98 | $0 (2024) |
| Relievant Medsystems, Inc. | $1,263 | 18 | $0 (2023) |
| Stimwave Technologies Incorporated | $828.86 | 10 | $0 (2022) |
| Spinal Simplicity, LLC | $642.72 | 10 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $614.99 | 39 | $0 (2024) |
| Vertos Medical, Inc. | $477.25 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140,419 | 143 | Aurora Spine, Inc. ($107,403) |
| 2023 | $126,109 | 186 | Aurora Spine, Inc. ($83,190) |
| 2022 | $164,082 | 224 | Aurora Spine, Inc. ($94,785) |
| 2021 | $135,743 | 190 | Medtronic, Inc. ($82,326) |
| 2020 | $48,410 | 200 | Medtronic USA, Inc. ($45,450) |
| 2019 | $62,220 | 176 | Medtronic USA, Inc. ($59,791) |
| 2018 | $58,544 | 186 | Medtronic USA, Inc. ($57,892) |
| 2017 | $59,528 | 200 | Medtronic USA, Inc. ($58,713) |
All Payment Transactions
1,505 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,283.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/16/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $206.64 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $70.60 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $67.30 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $53.09 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $209.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $169.30 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $57.29 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $38.72 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $229.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $39.71 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/11/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $502.00 | General |
| Category: Drug Infusion Systems | ||||||
| 12/05/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $12.99 | General |
| Category: Pain Management | ||||||
| 12/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $502.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/19/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Drug Infusion Systems | ||||||
| 11/19/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/15/2024 | Aurora Spine, Inc. | ZIP (Device) | Royalty or License | Cash or cash equivalent | $18,680.98 | General |
| Category: ORTHOPAEDIC FIXATION SYSTEM | ||||||
| 11/15/2024 | Aurora Spine, Inc. | ZIP (Device) | Royalty or License | Cash or cash equivalent | $18,680.98 | General |
| Category: ORTHOPAEDIC FIXATION SYSTEM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 10,999 | 18,780 | $7.0M | $2.2M |
| 2022 | 32 | 5,409 | 10,057 | $4.4M | $1.3M |
| 2021 | 23 | 5,558 | 9,037 | $4.0M | $1.1M |
| 2020 | 28 | 6,149 | 9,892 | $4.6M | $1.2M |
Total Patients
28,115
Total Services
47,766
Medicare Billing
$5.7M
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 2,485 | 5,211 | $2.4M | $795,106 | 32.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 4,668 | 8,635 | $1.6M | $519,918 | 31.7% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 1,440 | 1,783 | $1.3M | $429,992 | 32.1% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 677 | 919 | $551,400 | $178,491 | 32.4% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 1,058 | 1,412 | $494,200 | $156,012 | 31.6% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 20 | 20 | $70,000 | $17,017 | 24.3% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 21 | 54 | $77,760 | $15,043 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 101 | $45,450 | $10,300 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 133 | $42,560 | $10,016 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $31,320 | $7,315 | 23.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $29,640 | $6,765 | 22.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 54 | 61 | $24,960 | $6,416 | 25.7% |
| 62362 | Insertion of programmable spinal canal drug infusion pump | Facility | 2023 | 23 | 23 | $31,510 | $5,531 | 17.6% |
| 62350 | Insertion, revision, or repositioning of spinal canal tube for medication administration | Facility | 2023 | 16 | 16 | $42,510 | $5,428 | 12.8% |
| 64628 | Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | Facility | 2023 | 12 | 12 | $19,440 | $4,992 | 25.7% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 22 | 22 | $28,160 | $4,070 | 14.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 15 | 21 | $16,170 | $3,602 | 22.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 40 | 42 | $14,280 | $3,101 | 21.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 20 | 27 | $19,820 | $3,034 | 15.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 18 | 25 | $9,720 | $1,603 | 16.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 13 | 20 | $6,090 | $1,551 | 25.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 15 | 23 | $2,294 | $1,519 | 66.2% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 11 | 16 | $5,920 | $1,327 | 22.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 19 | $5,750 | $1,226 | 21.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 15 | 21 | $4,200 | $1,092 | 26.0% |
About Dr. Vipul Mangal, M.D
Dr. Vipul Mangal, M.D is a Anesthesiology healthcare provider based in Oxon Hill, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1336305002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vipul Mangal, M.D has received a total of $795,055 in payments from pharmaceutical and medical device companies, with $140,419 received in 2024. These payments were reported across 1,505 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($328,738).
As a Medicare-enrolled provider, Mangal has provided services to 28,115 Medicare beneficiaries, totaling 47,766 services with total Medicare billing of $5.7M. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Pain Medicine
- Location Oxon Hill, MD
- Active Since 08/01/2008
- Last Updated 07/26/2021
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1336305002
Products in Payments
- ZIP (Device) $337,609
- SYNCHROMED (Device) $122,986
- INTELLIS ADAPTIVESTIM (Device) $88,563
- INTELLIS (Device) $82,716
- RESTORE (Device) $38,405
- ADAPTIVESTIM (Device) $29,462
- SYNCHROMEDII (Device) $17,570
- VANTA ADAPTIVESTIM (Device) $16,032
- OSTEOCOOL RF ABLATION SYSTEM (Device) $8,144
- RESTORESENSORSURESCAN (Device) $6,014
- OSTEOCOOL RF ABLATION (Device) $4,549
- VECTRIS (Device) $3,239
- LIORESAL (Device) $2,500
- O-ARM-ST (Device) $2,478
- INTERSTIM (Device) $2,457
- Proclaim Family of SCS IPGs (Device) $2,390
- Intracept (Device) $1,263
- KYPHON Balloon Kyphoplasty (Device) $1,255
- MYSTIM (Device) $937.13
- WaveWriter Alpha Prime 16 (Device) $881.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.